Adipose-Derived Stem Cells (ASCs) for Tissue Engineering by Tremp, Mathias et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
7 
Adipose-Derived Stem Cells (ASCs)  
for Tissue Engineering 
Mathias Tremp1, Souzan Salemi1, Rita Gobet2, 
 Tullio Sulser1 and Daniel Eberli1 
1University Hospital Zürich, Laboratory for Tissue Engineering and Stem Cell Therapy, 
Department of Urology, Zürich,  
2Division of Pediatric Urology, Department of Pediatric Surgery,  
University Children’s Hospital, Zürich 
Switzerland 
1. Introduction  
A current challenge in the field of tissue engineering is soft tissue replacement. Techniques 
for soft tissue reconstruction include use of autologous fat transplantation, alloplastic 
implants and autologous tissue flaps. However, these approaches have disadvantages, 
including donor-site morbidity, implant migration, foreign body reaction and immune 
system rejection. The use of autologous stem cells expanded in vitro and combined with 
novel biomaterials for organ reconstruction offers a potential solution for replacement of 
tissue or whole organs. Stem cells, first identified in embryonic tissue and later in numerous 
adult tissues, possess the unique capacity to differentiate into wide range of tissue types. 
However, although embryonic cells are the most flexible of stem cell lines, they raise the 
problem of ethical issues. For tissue engineering, candidates of stem cells include embryonic 
stem cells (Ahn, et al.), induced pluripotent stem cells (iPS) (Crisan, et al.;2008, Parker, et 
al.;2007) and adult stem cells. The ability of adult stem cells to divide or self-renewal make 
them attractive source of stem cells for use in tissue engineering. A significant amount of 
current interest has focused on the possibility that adult human stem cells are the 
therapeutic alternative to embryonic stem cells because of their plasticity (Aoki, et al.;2010). 
The presence of self-renewing cells within the bone marrow of mice was reported in 1963 
which was later known as hematopoietic stem cells (HSCs) (Becker, et al.;1963, Zhang, et 
al.;1999). Several years later, HSCs were identified in umbilical cord blood by other 
investigators (Aust, et al.; 2004, Dellavalle, et al.;2007). Furthermore, several other adult stem 
cell types such as neural stem cells (Dellavalle, et al.; 2007, Guilak, et al.;2010), were isolated 
and identified. Moreover, a population of plastic adherent cells were isolated from 
collagenase digests of adipose tissue.  
Adipose tissue derived stem cells were termed as: adipose derived stem/stromal cells 
(ASCs), adipose-derived adult stem (ADAS) cells, adipose-derived adult stromal cells, 
adipose-derived stromal cells (ADSCs), adipose stromal cells (ASCs), adipose mesenchymal 
stem cells (AdMSCs), lipoblast, pericyte, preadipocyte, and processed lipoaspirate (PLA) 
cells. To prevent the confusion in the literature, the International Fat Applied Technology 
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Society reached a consensus to adopt the term “adipose-derived stem cells” (ASCs) to 
identify the isolated, plastic-adherent, multipotent cell population (Gimble, et al.;2007). 
Adipose tissue derives from the mesodermal layer of the embryo and develops both pre- 
and postnatally (Gonda, et al.;2008, Kakudo, et al.;2008). Researchers studying the 
development of adipose tissue have long worked with a fibroblastic cell line, known as 
preadipocytes, isolated from adipose tissue (Cowherd, et al.;1999, Gregoire, et al.;1998, 
Kirkland and Hollenberg;1998, Nam and Lobie;2000, Sorisky;1999).   
The reason why adipose tissue would contain a stem cell population is not still clear. There 
is some discussion whether the cells are subpopulation of fibroblasts reside within the fat 
tissue or are perhaps mesenchymal or peripheral blood stem cells passing through the fat 
tissue (Crisan, et al.; 2008, Dellavalle, et al.; 2007).  
The ASCs represent a readily available source for isolation of potentially useful stem cells 
(Sterodimas, et al.; 2010). In culture, they have shown to have an impressive developmental 
plasticity, including the ability to undergo multilineage differentiation and self-renewal 
(Liu, et al.; 2009). When ASCs are compared with BM-MSCs, further similarities have been 
demonstrated in regards to their growth kinetics, cell senescence, gene transduction 
efficiency (De Ugarte, et al.; 2003), as well as CD surface marker expression (Gronthos, et al.; 
2001, Katz, et al.; 2005, Zuk, et al.; 2002) and gene transcription (Katz, et al.; 2005). Compared 
to bone marrow MSCs, ASCs have potential advantages for tissue engineering application, 
because of the tissue accessibility, multipotency and ease of isolation without painful 
procedures or donor site injury. 
In this chapter we will discuss the potential use of adipose-derived stem cells in the field of 
tissue engineering.   
2. Isolation and expansion of ASCs 
The initial methods to isolate cells from adipose tissue were pioneered by Rodbell and 
colleagues in the 1960s (Rodbell; 1966, Rodbell; 1966, Rodbell and Jones; 1966) using rat fat 
tissue. These methods were further adapted for human tissues by several other groups 
(Deslex, et al.; 1987, Engfeldt, et al.; 1980, Ho, et al.; 2010). The current methods for isolating 
ASCs rely on a collagenase digestion followed by centrifugal separation to isolate the 
stromal/vascular cells from primary adipocytes. The pellet is resuspended with a basal 
medium containing 10% foetal bovine serum (Estes, et al.; 2008). The cell suspension is 
filtered through 100 µm cell strainer and the cells are plated and incubated at 37°C in the 
presence of 5% CO2. The medium is changed every second day until the cells reach 80-90% 
confluence. A large number of ASCs can be harvested in this manner, with yields of 
approximately 250,000 cells per gram of tissue (Aust, et al.; 2004, Guilak, et al.; 2010). In 
order to remove the use of animal products in human ASC cultures, a very low human 
serum expansion medium and a completely serum-free medium have been recently 
reported (Parker, et al.; 2007). Furthermore it was reported that use of platelet- rich plasma 
can enhance the proliferation of human ASCs. These results can support the clinical 
application of platelet-rich plasma for cell based, soft-tissue engineering and wound healing 
(Kakudo, et al.; 2008).  
ASCs should be harvested at 80% confluence for freezing. Cryopreservation medium 
consists of 80% fetal bovine serum, 10% dimethylsulfoxide (DMSO) and 10% DMEM/Ham’s 
F-12. The cells should be stored in a final concentration of 1–2 million viable cells per 
milliliter of cryopreservation medium. Aliqouted vials are first frozen in an alcohol freezing 
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container and store and are stored at -80°C overnight. On the next day, the frozen vials can 
be transferred to a liquid nitrogen container for long-term storage. Successful storage of 
ASCs more than 6 months has been shown. This ensures the availability of autologous 
banked ASCs for clinical applications in the future (De Rosa, et al.;2009, Gonda, et al.;2008).  
2.1 Characterization of ASCs 
In order to characterize the undifferentiated animal or human ASC cells cultured in vitro 
flow cytometric and immunohistochemical methods are widely used (Gronthos, et al.; 2001, 
Zuk, et al.; 2001). The cell surface phenotype of ASC is quite similar to MSCs (mesenchymal 
stem cells). Both ASC and MSC cells express CD29, CD44, CD71, CD90, and CD105 (Zuk, et 
al.; 2002). In contrast, no expression of the hematopoietic lineage markers CD31, CD34 and 
CD45 was observed in either of the cultures. In addition the ASC cells express the neutral 
endopeptidase (CD10 or common acute lymphocytic leukemia antigen CALLA), 
aminopeptidase (CD13), and ecto nucleotidase (CD73). Furthermore, ASC cells produce 
Type I and Type III collagens, osteopontin, ostenectin, Thy-1 (CD90), and MUC-18 (CD146) 
(Gimble and Guilak; 2003).  
Different investigator have reported different pattern of expression. For example, while 
Gronthos et al. (Gronthos, et al.;2001) detected CD34 and VCAM (CD106) on ASC cells, Zuk 
et al. (Zuk, et al.;2002) did not. Likewise, while Zuk et al. (Zuk, et al.;2002) detected Stro-1, 
Gronthos et al. did not. These discrepancies could be due to the differences in cell isolation 
methods, how long the cells were cultured prior to analysis and sensitivity differences 
between immunohistochemical and flow cytometric detection methods (Zuk, et al.;2002, 
Zuk, et al.;2001). 
3. ASCs applications  
Adipose tissue has proven to serve as an abundant source of adult stem cells with 
multipotent properties suitable for tissue engineering and regenerative medical 
applications. ASCs can be differentiated into variety of cell types. Differentiation is 
commonly induced by insulin, dexamethasone, cyclic AMP agonist, ǃ-glycerophosphate, 
heparin, ascorbate and different cytokines depending on the lineage type.  
ASCs like BM-MSCs, differentiate in vitro towards soft tissue such adipocytes, smooth 
muscle and cardiac myocytes when treated with established lineage-specific factors. In 
addition they can differentiate toward musculoskeletal tissues such as osteocytes, myocytes 
and chondrocytes. Furthermore neurogenic differentiation of these cells is reported by 
several investigators.  
3.1 ASCs differentiation 
3.1.1 Adipogenesis 
ASCs in response to inductive compounds including glucocorticoid receptor ligands 
(dexamethasone), insulin, cyclic AMP agonist (forskolin) and peroxisome proliferator-
activated receptor gamma (PPARǄ) undergo adipogenic differentiation (Farmer; 2006, 
Hauner, et al.; 1989, Lazar; 2005, Zuk, et al.; 2001). During the differentiation process ASCs 
reduce their proliferation rate and undergo morphological changes. ASCs are induced in the 
adipocyte differentiation medium containing biotin, d-pantothenate, dexamethasone, 
methylisobutylxanthine, insulin and equivalent PPARγ agonist. After induction for 2 weeks 
in adipogenic medium the human ASC contain vacuoles filled with neutral lipid cells which 
www.intechopen.com
  
Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 
 
182 
can be further stained for intracellular lipid droplets accumulation using an Oil Red O stain 
(Preece;1972).  
In addition, these cells secrete increased amounts of the adipocyte protein leptin, and 
transcribe adipogenic mRNAs such as the fatty acid binding protein, aP2 and lipoprotein 
lipase (Halvorsen, et al.; 2001, Hauner, et al.; 1989, Sen, et al.; 2001). Some of these 
parameters such as leptin, aP2 mRNA levels were quantified and found to be increased by 
several hundred-fold during the differentiation process (Halvorsen, et al.; 2001, Sen, et al.; 
2001). It is reported that ASCs harvested from female mice differentiate more efficiently into 
adipocytes than those from male mice (Ogawa, et al.; 2004).  
One of the most important uses of ASCs is for the replacement of adipose tissue itself. Large 
soft tissue defects are a common problem following trauma, burns and oncological 
resections. Several studies demonstrated the in vitro differentiation of ASCs along 
adipogenic lineages, including the accumulation of intracellular lipid droplets, and the 
expression of characteristic proteins and enzymes (Ogawa, et al.; 2004, Tchkonia, et al.; 2002, 
Zuk, et al.; 2002). ASCs were used to seed artificial scaffolds and were further implanted 
subcutaneously in mice and rats (von Heimburg, et al.; 2001, von Heimburg, et al.; 2001). 
The cell-seeded grafts showed significant neovascularisation of the implant, as well as 
penetration of the preadipocytes or ASCs into the scaffolding, and their differentiation into 
mature lipid-laden adipocytes. 
3.1.2 Smooth muscle  
ASCs can be differentiated to smooth muscle cells (SMCs) and might offer a cell source for 
hollow organ engineering. For myogenic differentiation ASCs at passages 3 through 5 are 
cultured in smooth muscle inductive medium consisting of MCDB131 supplemented with 
1% FBS and 100u/ml of heparin for up to 6 weeks at 37°C with 5% CO2. The media is 
changed every 3 days and cell splitting is not required (Jack, et al.; 2009).  
The cellular changes after differentiation can be investigated by real- time PCR at mRNA 
level. As reported the expression of muscle actin (SMA), calponin and myosin heavy chain 
showed an increase after growth in differentiation medium (Jack, et al.; 2009). The same was 
observed at protein levels, induction media induced differentiation of the ASCs into a 
smooth muscle phenotype in which the expression of smooth muscle specific proteins SMA, 
caldesmon, and myosin heavy chain (MHC) was increased (Jack, et al.; 2009). 
Differentiation is a complex process and has a dramatical effect on cell size, shape, 
membrane potential, metabolic activity and responsiveness to external signals. One of the 
main characteristic of SMCs is their contractility which plays important roles in 
angiogenesis, blood vessel maintenance, and mechanical regulation of hollow organs such 
as bladder.  
Differentiated SMCs can show two specific phenotypes, which vary from synthetic and 
proliferative to contractile and quiescent (Beamish, et al.; 2010). SMCs exhibit a contractile 
phenotype characterized by high expression of specific contractile proteins including SMA, 
calponin, SM22, smoothelin, h-caldesmon and smooth muscle myosin heavy chain (SM-
MHC) (Owens, et al.; 2004, Shanahan, et al.; 1993).  
Since differentiated human ASCs express smooth muscle specific proteins they may prove 
to be of value in the repair of smooth muscle defects in the gastrointestinal and urinary 
tracts. Juan et al. reported that the ASCs from different sites show different myogenic 
differentiation abilities in vitro. ASCs from the adipose tissues of the nape of the neck and 
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vicinity of epididymis can be used as ideal seed cells for tissue engineering of lower urinary 
tract (Yuan, et al.; 2010). Similar study was performed by other group using human 
subcutaneous and omental adipose tissues. They could show that subcutaneous adipose 
tissue has higher differentiation capacity than omental adipose tissue which can be a 
suitable cell source for use in regenerative medicine (Toyoda, et al.; 2009). 
3.1.3 Osteogenesis. Bone defect repair 
In the past decade, several groups isolated cells from the adipose tissue of humans and 
other species capable of differentiating into osteoblasts in vitro (Dragoo, et al.; 2003, Mizuno, 
et al.; 2002, Zuk, et al.; 2001). ASC cells differentiate into osteoblast-like cells in the presence 
of ascorbate, b-glycerophosphate, dexamethasone and vitamin D3.  
For osteogenic differentiation confluent ASCs cells are incubated for 3 weeks in DMEM 
containing 10% FBS, 100 nM dexamethasone, 10 mM ǃ-glycerophosphate and 50 μM L-
ascorbic acid-2-phosphate. After fixation cells are incubated at 37°C for 1 hour with 0.16% 
naphthol AS-TR phosphate and 0.8% Fast Blue BB dissolved in 0.1 M tris buffer (pH 9.0). For 
osteogenic differentiation cells were also incubated in 1% alizarin red S for 3 minutes to 
detect calcium deposition (Sakuma, et al.; 2009). 
Over a 2- 4 week period in vitro , both human and rat ASC cells deposit calcium phosphate 
mineral within their extracellular matrix, and express osteogenic genes. Under osteogenic 
conditions ASCs are observed to express genes and proteins associated with osteoblasts 
phenotypes such as osteopontin, osteonectin, osteocalcin collagen type I, BMP-2 and BMP-4 
(Halvorsen, et al.; 2001, Zuk, et al.; 2001). In addition ASCs are able to form mineralized 
matrix in vitro in both long term 2-D or 3-D osteogenic cultures. 
In vivo, ASC cells embedded in porous cubes of hydroxyapatite/tricalcium phosphate form 
bone were used as implants in immunodeficient mice (Hicok, et al.; 2004). New osteoid, 
derived from the human ASC cells, is present within a 6-week incubation period (Hicok, et 
al.; 2004). This finding indicates that ASCs cells will have therapeutic applications in bone 
repair. The first case of autologous ASC use for osseous repair has been reported in the 
treatment of a calvarial defect in a7-year-old girl (Lendeckel, et al.; 2004). Using different 
type of scaffolds, human ASC can form bone in immunodefficient mice (Hicok, et al.; 2004, 
Lee, et al.; 2003). 
3.1.4 Myogenesis: skeletal muscle repair 
There is several line of evidence that ASC cells can differentiate along each of the myocyte 
lineage pathways when cultured in myogenic induction medium containing 0.1 mM 
dexamethasone, 50 mM hydrocortisone, 10% FBS and 5% horse serum. ASCs express MyoD 
and myogenin, transcription factors regulating skeletal muscle differentiation (Pittenger, et 
al.; 1999, Zuk, et al.; 2001).  
Skeletal myogenesis is characterized by a period of myoblast proliferation, followed by the 
expression of muscle-specific proteins and fusion to form multinucleated myotubules. Early 
myogenic differentiation is characterized by the expression of several myogenic regulatory 
factors including myogenic determination factor MyoD1 (Weintraub, et al.; 1991). 
Terminally differentiated myoblasts can be characterized by the expression of myosin and 
the presence of multiple nuclei (Silberstein, et al.; 1986).  
In the first in vivo report, F Bacou et al injected ASCs into the anterior tibialis muscle of 
rabbits following cardiotoxin-induced injury. Consistent with prior work using satellite cells 
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treated muscles were found to be heavier, have an increased fibre area cross-section and 
exert greater maximal force (Boubaker el Andalousi, et al.; 2002). 
3.1.5 Chondrogenesis 
ASCs display chondrogenic characteristics following induction with ascorbate, 
dexamethasone and transforming growth factor-β (Awad, et al.; 2003, Huang, et al.; 2004, 
Zuk, et al.; 2001). Under inductive conditions ASCs express aggrecan, chondroitin sulphate, 
collagen type II and IV and proteoglycans associated with chondrogenic phenotype.(Awad, 
et al.; 2004, Erickson, et al.; 2002, Wickham, et al.; 2003, Zuk, et al.; 2001) 
For chondrogenic differentiation, ASCs cells are grown to confluency in 30-mm dishes and 
incubated for 3 weeks in DMEM containing 1% FBS, 50 mM L-ascorbic acid-2-phosphate, 40 
mg/ml proline, 100 mg/ml pyruvate, 10 ng/ml transforming growth factor (Harriman, et 
al.)-b3, and 1x ITS. Induction medium is replaced every 3 days. At the indicated time points, 
differentiated cells are fixed for 1h with 4% paraformaldehyde and rinsed with PBS. 
Accumulation of chondrocyte matrix is detected with alcian blue staining (pH 2.5, Wako) 
(Matsumoto, et al.; 2008). 
3.1.6 Neuronal differentiation 
There is preliminary evidence suggesting that human ASCs can display neuronal and/or 
oligodendrocytic markers. ADSC at passages 2–5 are seeded in six-well plates at 40%–60% 
confluence. After three washes with PBS, the cells are induced with NIM (DMEM 
supplemented with 500 mM IBMX, 200 mM INDO, and 5 mg/ml insulin) for 1 hr. The cells 
are then examined for the expression of neuronal markers S100, NF70, and nestin followed 
by hematoxylin-eosin (HE) staining (Ning, et al.; 2006).  
The in vivo test for the therapeutic potential of ASCs looked at their effects when injected 
intraventricularly in rats. ASCs survived with increased engraftment at the site of injury 
compared with controls. Neural lineage markers microtubule-associated protein-2 and glial 
fibrillary acidic protein were expressed in some engrafted cells. Behavioural tests of the 
motor and sensory systems showed clear improvements in those treated with ASCs after 
infarct (Kang, et al.; 2003). It is not clear whether transplanted cells replaced the lost neurons 
or provided a support role for existing stem cells and injured neurons. Furthermore, in a  co-
culture model, Kang et al. studied the interactions between neural stem cells (NSCs) and 
ASCs. In comparison to laminin-coated dishes, ASC feeder layers showed ability to support 
the differentiation and survival of NSCs over 14 days in culture. 
4. Biomaterials in tissue engineering with ASCs 
Currently, autologous and allogenic adipose tissues represent a ubiquitous source of 
material for fat reconstructive therapies. However, these approaches are limited, and often 
accompanied by a 40–60% reduction in graft volume following transplantation.  A number 
of factors including a stable scaffold support structure and vascularisation is necessary to 
support de novo adipogenesis and long-term maintenance of adipose tissue formation within 
adipose tissue engineered constructs (Patrick, et al.; 2002). Recently, cell-based approaches 
utilizing adipogenic progenitor cells in combination with biomaterial carriers for fat tissue 
engineering have been developed and were reported to promote both short-term in vivo 
adipogenesis and to repair defect sites (Borges, et al.; 2003, Patrick, et al.; 1999). To date, 
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however the efficacy of exogenously delivered stem cell populations to support the 
generation of long-term volume stable adipose tissue in vivo is restricted by suboptimal 
properties of their biomaterial carriers including insufficient biocompatibility and rapid 
scaffold degradation rates (Patrick, et al.; 2002).  
For functional tissue replacement such as bone, Silk-based biomaterials have previously 
been demonstrated to offer exceptional benefits over conventional synthetic (e.g. poly-
glycolic and lactic acid copolymers) and natural (e.g. collagen type I) biomaterials (Meinel, 
et al.; 2004). The slow degradation and mechanical integrity of silk scaffolds in comparison 
with other conventional biomaterials such as collagen and PLA, above all for long-term in 
vivo studies, suggest that silk fibroin-based scaffolds would be an optimal biomaterial for 
long-term adipose tissue growth and function (Mauney, et al.; 2007). Also, previous studies 
have demonstrated the ability of adipocytes to secrete various paracrine factors which can 
positively influence both the migration and differentiation of preadipocytes (Shillabeer, et 
al.; 1989). Mauney et al. studied biomaterials derived from silk fibroin prepared by aqueous 
(AB) and organic (HFIP) solvent-based processes, along with collagen (COL) and poly-lactic 
acid (PLA)-based scaffolds in vitro and in vivo for their utility in adipose tissue engineering 
strategies (Mauney, et al.; 2007). 
For in vitro studies, they used adipose-derived mesenchymal stem cells (hASCs) and seeded 
them on the various biomaterials and cultured them for 21 days in the presence of 
adipogenic stimulants (AD). In their study, hASCs (and hMSCs) cultured on all biomaterials 
in the presence of AD showed significant upregulation of adipogenic mRNA transcript 
levels (e.g. GLUT4) to similar extents when compared to noninduced controls (Mauney, et 
al.; 2007). Also, oil-red O analysis of hASC-seeded scaffold displayed substantial amounts of 
lipid accumulating adipocytes following cultivation with AD. Following a 4-week 
implantation period in a rat muscle pouch defect model, both AB and HFIP scaffolds 
supported in vivo adipogenesis either alone or seeded with hASCs (Mauney, et al.; 2007). On 
the other hand, COL and PLA scaffolds underwent rapid scaffold degradation and were 
irretrievable following the implantation period. The authors concluded that macroporous 
3D AB and HFIP silk fibroin scaffolds offer an important platform for cell-based adipose 
tissue engineering applications, and in particular, provide longer-term structural integrity to 
promote the maintenance of soft tissue in vivo (Mauney, et al.; 2007). 
Tissue-specific scaffolds and signalling systems are essential to differentiate stem cells into 
the required cells and use them effectively to construct three-dimensional (3D) tissues 
(Sterodimas, et al.; 2010). It has also been proved that adipose tissues engineered with ASCs 
and type I collagen scaffolds can serve in vivo for the replacement of damaged tissue (Lu, et 
al.; 2006). This has been confirmed by Zhang et al., where collagen I scaffold exhibited 
excellent cellular compatibility and can be used as a vehicle for adipose tissue engineering 
(Zhang, et al.; 2007).  
Porous collagenous microbeads can be useful as injectable cell delivery vehicles for adipose-
derived stem cells, allowing ex vivo proliferation and differentiation on particles that are 
small enough to be injected into a defect and molded into the desired shape without 
migration of the cells. The cell-seeded microbeads can be injected through a needle into the 
wound site, and agglomeration of the microbeads can retain the cells and microbeads in the 
site (Rubin, et al.; 2007). Furthermore, the use of natural material hold promises in tissues 
engineering.  
Placental decellular matrix (PDM) holds potential as a scaffold for adipose tissue 
engineering applications. The placenta is a rich source of human extracellular matrix (ECM) 
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components that can be harvested without harm to the donor. Constructs derived from the 
ECM may mimic the native environment of the body, promoting normal cellular 
organization and behavior. Natural materials also have advantages in terms of ease of 
processing, biodegradability and biocompatibility (Schmidt and Baier; 2000). Cell-adhesive 
placental decellular matrix scaffolds facilitate proliferation and viability, while 
differentiation is augmented when the cells are encapsulated in non-adhesive cross-linked 
hyaluronan (XLHA) scaffolds (Flynn, et al.; 2008). Incorporation of XLHA into the PDM 
scaffolds may improve the construct bulking properties and may influence cellular 
infiltration, differentiation and wound healing (Shu XZ; 2004). 
Other candidate for suitable scaffolds is non-woven polyglycolic acid (PGA) and hyaluronic 
acid gel. In a recent study it has been shown that more adipose-tissue-like construct is 
regenerated when using type I collagen sponge than when the non-woven polyglycolic acid 
or hyaluronic acid gel are used (Itoi, et al.; 2010). In addition, significant evidence has been 
shown that ASCs and PLGA spheres can be used in a clinical setting to generate adipose 
tissue as a noninvasive soft tissue filler (Choi, et al.; 2006).  
Altman et al. could show that human adipose-derived stem cells seeded on a silk fibroin-
chitosan scaffold enhance wound healing and show differentiation into fibrovascular, 
endothelial, and epithelial components of restored tissue (Altman, et al.; 2009). In addition, 
it has been shown that transfection of human ASCs with liposome- enveloped xenogenic 
protein from a neonatal rat tissue preparation can induce differentiation of stem cells along 
the directed lineage (Gaustad, et al.; 2004). These observations support the hypothesis that 
the inductive biochemical and structural cues of the microenvironment are conserved across 
species and that a silk fibroin-chitosan delivery vehicle can provide a beneficial niche in 
supporting migration, proliferation, and differentiation of the applied cells (Altman, et al.; 
2009). 
Another complex biomolecule which has sparked great interest for tissue engineering is 
Hyaluronic acid which has been stated to support the growth and development of 
progenitor cells (Brun, et al.; 1999, Solchaga, et al.; 1999). The material has a progressive rate 
of biodegradation, lacks cytotoxicity and does not induce a systemic immune response or 
chronic inflammation in a human in vivo model (Stillaert, et al.; 2008).  Hyaluronic acid-
based (HA) scaffolds were demonstrated to be suitable materials for soft-tissue 
regeneration; they maintain volume when seeded with preadipocytes. Hemmrich et al. 
evaluated, in vitro and in vivo, human preadipocytes seeded onto plain hyaluronan benzyl 
ester (HYAFF®11) or HYAFF®11 coated with the extracellular matrix glycosaminoglycan 
hyaluronic acid and they found extensive formation of new vessels throughout the construct 
but with only minor adipose tissue (Hemmrich, et al.; 2005). 
Long-standing, 3D predefined-shape adipose tissue from hAD-MSCs of human adipose 
tissue remains a challenge. Lin et al. cultured scaffolds (Gelatin sponges, monofilament 
polypropylene and polyglycolic acid meshes) with hAD-MSCs in adipogenic medium for 2 
weeks before implantation, and implanted scaffolds were harvested after 2, 4, and 6 months 
in vivo. All of the successfully harvested scaffolds were filled with newly formed adipose 
tissue and had retained their predefined shape and dimensions (Lin, et al.; 2008). It has been 
shown that hAD-MSCs are not successful soft tissue filler if used alone (Lin, et al.; 2008, 
Moseley, et al.; 2006). 
There are numerous adipose tissue engineering culture strategies in which the core tissue 
engineering principles comprising appropriate cells, scaffold, and microenvironment are 
optimized (Patrick; 2001). Specifically, there are static versus dynamic culture, co-
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cultivation, and addition of growth factors, vascularization, and long-term sustainability of 
engineered constructs. The advantage of dynamic culture includes increased nutrient and 
oxygen delivery to cells within a 3D construct (Frye and Patrick; 2006). Improved bioreactor 
designs to address direct perfusion conditions are necessary to advance dynamic culture 
techniques (Choi, et al.; 2010). 
It has been shown that hASCs express pericyte lineage markers in vivo and in vitro, exhibit 
increased migration in response to PDGF-BB in vitro, exhibit perivascular morphology when 
injected in vivo, and contribute to increases in microvascular density during angiogenesis by 
migrating toward vessels (Amos, et al.; 2008). In cell-assisted lipotransfer (CAL), autologous 
ASCs are used in combination with lipoinjection (e.g. Parry-Romberg syndrome). A stromal 
vascular fraction (SVF) containing ASCs is freshly isolated from half of the aspirated fat and 
recombined with the other half. The preliminary results suggest that CAL is effective and 
safe for soft-tissue augmentation and superior to conventional lipoinjection and 
microvasculature can be detected more prominently in CAL fat (Yoshimura, et al.; 2008). 
Recently, adipose stem cells have proved to selectively induce neovascularisation and 
increase the viability of random-pattern skin flaps. This mechanism might be both due to the 
direct differentiation of ASCs into endothelial cells and the indirect effect of angiogenic 
growh factors released from ASCs (Lu, et al.; 2008). 
5. Conclusion 
ASCs provide an abundant and readily accessible source of multipotent stem cells. The use 
of autologous stem cells expanded in vitro and combined with novel selected biomaterials 
for organ reconstruction offers a potential solution for replacement of tissue or whole 
organs. ASC does have one important advantage over the other sources of stem cells namely 
easy availability. There is no human tissue as expendable as adipose tissue, making it 
relatively easy to isolate adequate numbers of ASCs for possible human therapies. Human 
ASCs can be ideal cell source for tissue engineering. They are available in large quantities of 
cells per individual, multipotent, are transplantable in an autologous setting. 
However, further studies are needed before ASCs can be used clinically. In particular, 
investigators need to demonstrate the safety and efficacy of ASCs cells in animal models, 
either alone or in combination with novel biomaterial scaffolds.  
6. Acknowledgment  
Both the authors Dr. Mathias Tremp and Dr. Souzan Salemi contributed equivalently in 
writing this chapter. 
7. References  
Ahn, H. H., Lee, J. H., Kim, K. S., Lee, J. Y., Kim, M. S., Khang, G., Lee, I. W., and Lee, H. B. 
(2008). Polyethyleneimine-mediated gene delivery into human adipose derived 
stem cells. Biomaterials Vol.29, No.15, pp. 2415-22, ISSN 0142-9612 
Altman, A. M., Yan, Y., Matthias, N., Bai, X., Rios, C., Mathur, A. B., Song, Y. H., and Alt, E. 
U. (2009). IFATS collection: Human adipose-derived stem cells seeded on a silk 
fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury 
model. Stem Cells Vol.27, No.1, pp. 250-8, ISSN 1549-4918  
www.intechopen.com
  
Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 
 
188 
Amos, P. J., Shang, H., Bailey, A. M., Taylor, A., Katz, A. J., and Peirce, S. M. (2008). IFATS 
collection: The role of human adipose-derived stromal cells in inflammatory 
microvascular remodeling and evidence of a perivascular phenotype. Stem Cells 
Vol.26, No.10, pp. 2682-90, ISSN 1549-4918  
Aoki, T., Ohnishi, H., Oda, Y., Tadokoro, M., Sasao, M., Kato, H., Hattori, K., and Ohgushi, 
H. (2010). Generation of induced pluripotent stem cells from human adipose-
derived stem cells without c-MYC. Tissue Eng Part A Vol.16, No.7, pp. 2197-206, 
ISSN 1937-335X  
Aust, L., Devlin, B., Foster, S. J., Halvorsen, Y. D., Hicok, K., du Laney, T., Sen, A., Willingmyre, 
G. D., and Gimble, J. M. (2004). Yield of human adipose-derived adult stem cells from 
liposuction aspirates. Cytotherapy Vol.6, No.1, pp. 7-14, ISSN 1465-3249  
Awad, H. A., Halvorsen, Y. D., Gimble, J. M., and Guilak, F. (2003). Effects of transforming 
growth factor beta1 and dexamethasone on the growth and chondrogenic 
differentiation of adipose-derived stromal cells. Tissue Eng Vol.9, No.6, pp. 1301-12, 
ISSN 1076-3279  
Awad, H. A., Wickham, M. Q., Leddy, H. A., Gimble, J. M., and Guilak, F. (2004). 
Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, 
and gelatin scaffolds. Biomaterials Vol.25, No.16, pp. 3211-22, ISSN 0142-9612  
Beamish, J. A., He, P., Kottke-Marchant, K., and Marchant, R. E. (2010). Molecular regulation 
of contractile smooth muscle cell phenotype: implications for vascular tissue 
engineering. Tissue Eng Part B Rev Vol.16, No.5, pp. 467-91, ISSN 1937-3376  
Becker, A. J., Mc, C. E., and Till, J. E. (1963). Cytological demonstration of the clonal nature 
of spleen colonies derived from transplanted mouse marrow cells. Nature Vol.197, 
pp. 452-4, ISSN 0028-0836  
Borges, J., Mueller, M. C., Padron, N. T., Tegtmeier, F., Lang, E. M., and Stark, G. B. (2003). 
Engineered adipose tissue supplied by functional microvessels. Tissue Eng Vol.9, 
No.6, pp. 1263-70, ISSN 1076-3279  
Boubaker el Andalousi, R., Daussin, P. A., Micallef, J. P., Roux, C., Nougues, J., Chammas, 
M., Reyne, Y., and Bacou, F. (2002). Changes in mass and performance in rabbit 
muscles after muscle damage with or without transplantation of primary satellite 
cells. Cell Transplant Vol.11, No.2, pp. 169-80, ISSN 0963-6897  
Brun, P., Cortivo, R., Zavan, B., Vecchiato, N., and Abatangelo, G. (1999). In vitro 
reconstructed tissues on hyaluronan-based temporary scaffolding. J Mater Sci Mater 
Med Vol.10, No.10/11, pp. 683-8, ISSN 0957-4530 
Choi, J. H., Gimble, J. M., Lee, K., Marra, K. G., Rubin, J. P., Yoo, J. J., Vunjak-Novakovic, G., 
and Kaplan, D. L. (2010). Adipose tissue engineering for soft tissue regeneration. 
Tissue Eng Part B Rev Vol.16, No.4, pp. 413-26, ISSN 1937-3376  
Choi, Y. S., Cha, S. M., Lee, Y. Y., Kwon, S. W., Park, C. J., and Kim, M. (2006). Adipogenic 
differentiation of adipose tissue derived adult stem cells in nude mouse. Biochem 
Biophys Res Commun Vol.345, No.2, pp. 631-7, ISSN 0006-291X  
Cowherd, R. M., Lyle, R. E., and McGehee, R. E., Jr. (1999). Molecular regulation of 
adipocyte differentiation. Semin Cell Dev Biol Vol.10, No.1, pp. 3-10, ISSN 1084-9521  
Crisan, M., Yap, S., Casteilla, L., Chen, C. W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., 
Zheng, B., Zhang, L., Norotte, C., Teng, P. N., Traas, J., Schugar, R., Deasy, B. M., 
Badylak, S., Buhring, H. J., Giacobino, J. P., Lazzari, L., Huard, J., and Peault, B. 
www.intechopen.com
 
Adipose-Derived Stem Cells (ASCs) for Tissue Engineering 
 
189 
(2008). A perivascular origin for mesenchymal stem cells in multiple human 
organs. Cell Stem Cell Vol.3, No.3, pp. 301-13, ISSN 1875-9777  
De Rosa, A., De Francesco, F., Tirino, V., Ferraro, G. A., Desiderio, V., Paino, F., Pirozzi, G., 
D'Andrea, F., and Papaccio, G. (2009). A new method for cryopreserving adipose-
derived stem cells: an attractive and suitable large-scale and long-term cell banking 
technology. Tissue Eng Part C Methods Vol.15, No.4, pp. 659-67, ISSN 1937-3392  
De Ugarte, D. A., Morizono, K., Elbarbary, A., Alfonso, Z., Zuk, P. A., Zhu, M., Dragoo, J. L., 
Ashjian, P., Thomas, B., Benhaim, P., Chen, I., Fraser, J., and Hedrick, M. H. (2003). 
Comparison of multi-lineage cells from human adipose tissue and bone marrow. 
Cells Tissues Organs Vol.174, No.3, pp. 101-9, ISSN 1422-6405  
Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., Tagliafico, E., Sacchetti, B., Perani, L., 
Innocenzi, A., Galvez, B. G., Messina, G., Morosetti, R., Li, S., Belicchi, M., Peretti, 
G., Chamberlain, J. S., Wright, W. E., Torrente, Y., Ferrari, S., Bianco, P., and Cossu, 
G. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from 
satellite cells. Nat Cell Biol Vol.9, No.3, pp. 255-67, ISSN 1465-7392  
Deslex, S., Negrel, R., Vannier, C., Etienne, J., and Ailhaud, G. (1987). Differentiation of 
human adipocyte precursors in a chemically defined serum-free medium. Int J Obes 
Vol.11, No.1, pp. 19-27, ISSN 0307-0565  
Dragoo, J. L., Samimi, B., Zhu, M., Hame, S. L., Thomas, B. J., Lieberman, J. R., Hedrick, M. 
H., and Benhaim, P. (2003). Tissue-engineered cartilage and bone using stem cells 
from human infrapatellar fat pads. J Bone Joint Surg Br Vol.85, No.5, pp. 740-7, ISSN 
0301-620X  
Engfeldt, P., Arner, P., and Ostman, J. (1980). Influence of adipocyte isolation by collagenase 
on phosphodiesterase activity and lipolysis in man. J Lipid Res Vol.21, No.4, pp. 
443-8, ISSN 0022-2275 
Erickson, G. R., Gimble, J. M., Franklin, D. M., Rice, H. E., Awad, H., and Guilak, F. (2002). 
Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. 
Biochem Biophys Res Commun Vol.290, No.2, pp. 763-9, ISSN 0006-291X  
Estes, B. T., Diekman, B. O., and Guilak, F. (2008). Monolayer cell expansion conditions 
affect the chondrogenic potential of adipose-derived stem cells. Biotechnol Bioeng 
Vol.99, No.4, pp. 986-95, ISSN 1097-0290  
Farmer, S. R. (2006). Transcriptional control of adipocyte formation. Cell Metab Vol.4, No.4, 
pp. 263-73, ISSN 1550-4131 
Flynn, L. E., Prestwich, G. D., Semple, J. L., and Woodhouse, K. A. (2008). Proliferation and 
differentiation of adipose-derived stem cells on naturally derived scaffolds. 
Biomaterials Vol.29, No.12, pp. 1862-71, ISSN 0142-9612  
Frye, C. A., and Patrick, C. W. (2006). Three-dimensional adipose tissue model using low shear 
bioreactors. In Vitro Cell Dev Biol Anim Vol.42, No.5-6, pp. 109-14, ISSN 1071-2690  
Gaustad, K. G., Boquest, A. C., Anderson, B. E., Gerdes, A. M., and Collas, P. (2004). 
Differentiation of human adipose tissue stem cells using extracts of rat 
cardiomyocytes. Biochem Biophys Res Commun Vol.314, No.2, pp. 420-7, ISSN 0006-291X 
Gimble, J., and Guilak, F. (2003). Adipose-derived adult stem cells: isolation, 
characterization, and differentiation potential. Cytotherapy Vol.5, No.5, pp. 362-9, 
ISSN 1465-3249  
Gimble, J. M., Katz, A. J., and Bunnell, B. A. (2007). Adipose-derived stem cells for 
regenerative medicine. Circ Res Vol.100, No.9, pp. 1249-60, ISSN 1524-4571 
www.intechopen.com
  
Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 
 
190 
Gonda, K., Shigeura, T., Sato, T., Matsumoto, D., Suga, H., Inoue, K., Aoi, N., Kato, H., Sato, 
K., Murase, S., Koshima, I., and Yoshimura, K. (2008). Preserved proliferative 
capacity and multipotency of human adipose-derived stem cells after long-term 
cryopreservation. Plast Reconstr Surg Vol.121, No.2, pp. 401-10, ISSN 1529-4242  
Gregoire, F. M., Smas, C. M., and Sul, H. S. (1998). Understanding adipocyte differentiation. 
Physiol Rev Vol.78, No.3, pp. 783-809, ISSN 0031-9333  
Gronthos, S., Franklin, D. M., Leddy, H. A., Robey, P. G., Storms, R. W., and Gimble, J. M. 
(2001). Surface protein characterization of human adipose tissue-derived stromal 
cells. J Cell Physiol Vol.189, No.1, pp. 54-63, ISSN 0021-9541  
Guilak, F., Estes, B. T., Diekman, B. O., Moutos, F. T., and Gimble, J. M. (2010). 2010 Nicolas 
Andry Award: Multipotent adult stem cells from adipose tissue for 
musculoskeletal tissue engineering. Clin Orthop Relat Res Vol.468, No.9, pp. 2530-
40, ISSN 1528-1132  
Halvorsen, Y. D., Bond, A., Sen, A., Franklin, D. M., Lea-Currie, Y. R., Sujkowski, D., Ellis, P. 
N., Wilkison, W. O., and Gimble, J. M. (2001). Thiazolidinediones and 
glucocorticoids synergistically induce differentiation of human adipose tissue 
stromal cells: biochemical, cellular, and molecular analysis. Metabolism Vol.50, No.4, 
pp. 407-13, ISSN 0026-0495 
Halvorsen, Y. D., Franklin, D., Bond, A. L., Hitt, D. C., Auchter, C., Boskey, A. L., Paschalis, 
E. P., Wilkison, W. O., and Gimble, J. M. (2001). Extracellular matrix mineralization 
and osteoblast gene expression by human adipose tissue-derived stromal cells. 
Tissue Eng Vol.7, No.6, pp. 729-41, ISSN 1076-3279  
Harriman, G. R., Bogue, M., Rogers, P., Finegold, M., Pacheco, S., Bradley, A., Zhang, Y., and 
Mbawuike, I. N. (1999). Targeted deletion of the IgA constant region in mice leads 
to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol 
Vol.162, No.5, pp. 2521-9, ISSN 0022-1767  
Hauner, H., Entenmann, G., Wabitsch, M., Gaillard, D., Ailhaud, G., Negrel, R., and Pfeiffer, 
E. F. (1989). Promoting effect of glucocorticoids on the differentiation of human 
adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 
Vol.84, No.5, pp. 1663-70, ISSN 0021-9738  
Hemmrich, K., von Heimburg, D., Rendchen, R., Di Bartolo, C., Milella, E., and Pallua, N. 
(2005). Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into 
nude mice to evaluate potential for soft tissue engineering. Biomaterials Vol.26, 
No.34, pp. 7025-37, ISSN 0142-9612 
Hicok, K. C., Du Laney, T. V., Zhou, Y. S., Halvorsen, Y. D., Hitt, D. C., Cooper, L. F., and 
Gimble, J. M. (2004). Human adipose-derived adult stem cells produce osteoid in 
vivo. Tissue Eng Vol.10, No.3-4, pp. 371-80, ISSN 1076-3279 
Ho, J. H., Ma, W. H., Tseng, T. C., Chen, Y. F., Chen, M. H., and Lee, O. K. (2010). Isolation 
and Characterization of Multi-Potent Stem Cells from Human Orbital Fat Tissues. 
Tissue Eng Part A, pp., ISSN 1937-335X  
Huang, J. I., Zuk, P. A., Jones, N. F., Zhu, M., Lorenz, H. P., Hedrick, M. H., and Benhaim, P. 
(2004). Chondrogenic potential of multipotential cells from human adipose tissue. 
Plast Reconstr Surg Vol.113, No.2, pp. 585-94, ISSN 0032-1052  
Itoi, Y., Takatori, M., Hyakusoku, H., and Mizuno, H. (2010). Comparison of readily 
available scaffolds for adipose tissue engineering using adipose-derived stem cells. 
J Plast Reconstr Aesthet Surg Vol.63, No.5, pp. 858-64, ISSN 1878-0539 
www.intechopen.com
 
Adipose-Derived Stem Cells (ASCs) for Tissue Engineering 
 
191 
Jack, G. S., Zhang, R., Lee, M., Xu, Y., Wu, B. M., and Rodriguez, L. V. (2009). Urinary bladder 
smooth muscle engineered from adipose stem cells and a three dimensional synthetic 
composite. Biomaterials Vol.30, No.19, pp. 3259-70, ISSN 1878-5905  
Kakudo, N., Minakata, T., Mitsui, T., Kushida, S., Notodihardjo, F. Z., and Kusumoto, K. 
(2008). Proliferation-promoting effect of platelet-rich plasma on human adipose-
derived stem cells and human dermal fibroblasts. Plast Reconstr Surg Vol.122, No.5, 
pp. 1352-60, ISSN 1529-4242 
Kang, S. K., Lee, D. H., Bae, Y. C., Kim, H. K., Baik, S. Y., and Jung, J. S. (2003). Improvement 
of neurological deficits by intracerebral transplantation of human adipose tissue-
derived stromal cells after cerebral ischemia in rats. Exp Neurol Vol.183, No.2, pp. 
355-66, ISSN 0014-4886  
Katz, A. J., Tholpady, A., Tholpady, S. S., Shang, H., and Ogle, R. C. (2005). Cell surface and 
transcriptional characterization of human adipose-derived adherent stromal 
(hADAS) cells. Stem Cells Vol.23, No.3, pp. 412-23, ISSN 1066-5099  
Kirkland, J. L., and Hollenberg, C. H. (1998). Inhibitors of preadipocyte replication: 
opportunities for the treatment of obesity. Prog Mol Subcell Biol Vol.20, pp. 177-95, 
ISSN 0079-6484  
Lazar, M. A. (2005). PPAR gamma, 10 years later. Biochimie Vol.87, No.1, pp. 9-13, ISSN 
0300-9084  
Lee, J. A., Parrett, B. M., Conejero, J. A., Laser, J., Chen, J., Kogon, A. J., Nanda, D., Grant, R. 
T., and Breitbart, A. S. (2003). Biological alchemy: engineering bone and fat from 
fat-derived stem cells. Ann Plast Surg Vol.50, No.6, pp. 610-7, ISSN 0148-7043  
Lendeckel, S., Jodicke, A., Christophis, P., Heidinger, K., Wolff, J., Fraser, J. K., Hedrick, M. 
H., Berthold, L., and Howaldt, H. P. (2004). Autologous stem cells (adipose) and 
fibrin glue used to treat widespread traumatic calvarial defects: case report. J 
Craniomaxillofac Surg Vol.32, No.6, pp. 370-3, ISSN 1010-5182  
Lin, S. D., Wang, K. H., and Kao, A. P. (2008). Engineered adipose tissue of predefined shape 
and dimensions from human adipose-derived mesenchymal stem cells. Tissue Eng 
Part A Vol.14, No.5, pp. 571-81, ISSN 1937-3341  
Liu, Z. J., Zhuge, Y., and Velazquez, O. C. (2009). Trafficking and differentiation of 
mesenchymal stem cells. J Cell Biochem Vol.106, No.6, pp. 984-91, Issn 1097-4644  
Lu, F., Gao, J. H., Ogawa, R., Mizuro, H., and Hykusoku, H. (2006). Adipose tissues 
differentiated by adipose-derived stem cells harvested from transgenic mice. Chin J 
Traumatol Vol.9, No.6, pp. 359-64, ISSN 1008-1275  
Lu, F., Mizuno, H., Uysal, C. A., Cai, X., Ogawa, R., and Hyakusoku, H. (2008). Improved 
viability of random pattern skin flaps through the use of adipose-derived stem 
cells. Plast Reconstr Surg Vol.121, No.1, pp. 50-8, ISSN 1529-4242  
Matsumoto, T., Kano, K., Kondo, D., Fukuda, N., Iribe, Y., Tanaka, N., Matsubara, Y., 
Sakuma, T., Satomi, A., Otaki, M., Ryu, J., and Mugishima, H. (2008). Mature 
adipocyte-derived dedifferentiated fat cells exhibit multilineage potential. J Cell 
Physiol Vol.215, No.1, pp. 210-22, ISSN 1097-4652  
Mauney, J. R., Nguyen, T., Gillen, K., Kirker-Head, C., Gimble, J. M., and Kaplan, D. L. 
(2007). Engineering adipose-like tissue in vitro and in vivo utilizing human bone 
marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D 
scaffolds. Biomaterials Vol.28, No.35, pp. 5280-90, ISSN 0142-9612 
www.intechopen.com
  
Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 
 
192 
Meinel, L., Karageorgiou, V., Hofmann, S., Fajardo, R., Snyder, B., Li, C., Zichner, L., Langer, 
R., Vunjak-Novakovic, G., and Kaplan, D. L. (2004). Engineering bone-like tissue in 
vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 
Vol.71, No.1, pp. 25-34, ISSN 1549-3296  
Mizuno, H., Zuk, P. A., Zhu, M., Lorenz, H. P., Benhaim, P., and Hedrick, M. H. (2002). 
Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 
Vol.109, No.1, pp. 199-209; discussion 210-1, ISSN 0032-1052 
Moseley, T. A., Zhu, M., and Hedrick, M. H. (2006). Adipose-derived stem and progenitor 
cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg Vol.118, 
No.3 Suppl, pp. 121S-128S, ISSN 1529-4242 
Nam, S. Y., and Lobie, P. E. (2000). The mechanism of effect of growth hormone on 
preadipocyte and adipocyte function. Obes Rev Vol.1, No.2, pp. 73-86, ISSN 1467-7881  
Ning, H., Lin, G., Lue, T. F., and Lin, C. S. (2006). Neuron-like differentiation of adipose 
tissue-derived stromal cells and vascular smooth muscle cells. Differentiation Vol.74, 
No.9-10, pp. 510-8, ISSN 0301-4681  
Ogawa, R., Mizuno, H., Watanabe, A., Migita, M., Hyakusoku, H., and Shimada, T. (2004). 
Adipogenic differentiation by adipose-derived stem cells harvested from GFP 
transgenic mice-including relationship of sex differences. Biochem Biophys Res 
Commun Vol.319, No.2, pp. 511-7, ISSN 0006-291X  
Owens, G. K., Kumar, M. S., and Wamhoff, B. R. (2004). Molecular regulation of vascular 
smooth muscle cell differentiation in development and disease. Physiol Rev Vol.84, 
No.3, pp. 767-801, ISSN 0031-9333 
Parker, A. M., Shang, H., Khurgel, M., and Katz, A. J. (2007). Low serum and serum-free 
culture of multipotential human adipose stem cells. Cytotherapy Vol.9, No.7, pp. 
637-46, ISSN 1465-3249 
Patrick, C. W., Jr. (2001). Tissue engineering strategies for adipose tissue repair. Anat Rec 
Vol.263, No.4, pp. 361-6, ISSN 0003-276X  
Patrick, C. W., Jr., Chauvin, P. B., Hobley, J., and Reece, G. P. (1999). Preadipocyte seeded 
PLGA scaffolds for adipose tissue engineering. Tissue Eng Vol.5, No.2, pp. 139-51, 
ISSN 1076-3279  
Patrick, C. W., Jr., Zheng, B., Johnston, C., and Reece, G. P. (2002). Long-term implantation 
of preadipocyte-seeded PLGA scaffolds. Tissue Eng Vol.8, No.2, pp. 283-93, ISSN 
1076-3279  
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., 
Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999). 
Multilineage potential of adult human mesenchymal stem cells. Science Vol.284, 
No.5411, pp. 143-7, ISSN 0036-8075  
Preece, A. (1972). A Manual for Histologic Technicians. Boston, MA: Little, Brown and Co.  
Rodbell, M. (1966). Metabolism of isolated fat cells. II. The similar effects of phospholipase C 
(Clostridium perfringens alpha toxin) and of insulin on glucose and amino acid 
metabolism. J Biol Chem Vol.241, No.1, pp. 130-9, ISSN 0021-9258  
Rodbell, M. (1966). The metabolism of isolated fat cells. IV. Regulation of release of protein 
by lipolytic hormones and insulin. J Biol Chem Vol.241, No.17, pp. 3909-17, ISSN 
0021-9258  
Rodbell, M., and Jones, A. B. (1966). Metabolism of isolated fat cells. 3. The similar inhibitory 
action of phospholipase C (Clostridium perfringens alpha toxin) and of insulin on 
www.intechopen.com
 
Adipose-Derived Stem Cells (ASCs) for Tissue Engineering 
 
193 
lipolysis stimulated by lipolytic hormones and theophylline. J Biol Chem Vol.241, 
No.1, pp. 140-2, ISSN 0021-9258  
Rubin, J. P., Bennett, J. M., Doctor, J. S., Tebbets, B. M., and Marra, K. G. (2007). Collagenous 
microbeads as a scaffold for tissue engineering with adipose-derived stem cells. 
Plast Reconstr Surg Vol.120, No.2, pp. 414-24, ISSN 1529-4242  
Sakuma, T., Matsumoto, T., Kano, K., Fukuda, N., Obinata, D., Yamaguchi, K., Yoshida, T., 
Takahashi, S., and Mugishima, H. (2009). Mature, adipocyte derived, dedifferentiated 
fat cells can differentiate into smooth muscle-like cells and contribute to bladder 
tissue regeneration. J Urol Vol.182, No.1, pp. 355-65, ISSN 1527-3792 
Schmidt, C. E., and Baier, J. M. (2000). Acellular vascular tissues: natural biomaterials for tissue 
repair and tissue engineering. Biomaterials Vol.21, No.22, pp. 2215-31, ISSN 0142-9612  
Sen, A., Lea-Currie, Y. R., Sujkowska, D., Franklin, D. M., Wilkison, W. O., Halvorsen, Y. D., 
and Gimble, J. M. (2001). Adipogenic potential of human adipose derived stromal 
cells from multiple donors is heterogeneous. J Cell Biochem Vol.81, No.2, pp. 312-9, 
ISSN 0730-2312 
Shanahan, C. M., Weissberg, P. L., and Metcalfe, J. C. (1993). Isolation of gene markers of 
differentiated and proliferating vascular smooth muscle cells. Circ Res Vol.73, No.1, 
pp. 193-204, ISSN 0009-7330  
Shillabeer, G., Forden, J. M., and Lau, D. C. (1989). Induction of preadipocyte differentiation 
by mature fat cells in the rat. J Clin Invest Vol.84, No.2, pp. 381-7, ISSN 0021-9738  
Shu XZ, P. G. (2004). Therapeutic biomaterials from chemically modified hyaluronan. In: 
Garg HG, Hales CA, editors Chemistry and biology of hyaluronan. Amsterdam: 
Elsevier Press, pp. 475-504  
Silberstein, L., Webster, S. G., Travis, M., and Blau, H. M. (1986). Developmental progression 
of myosin gene expression in cultured muscle cells. Cell Vol.46, No.7, pp. 1075-81, 
ISSN 0092-8674  
Solchaga, L. A., Dennis, J. E., Goldberg, V. M., and Caplan, A. I. (1999). Hyaluronic acid-
based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J 
Orthop Res Vol.17, No.2, pp. 205-13, ISSN 0736-0266  
Sorisky, A. (1999). From preadipocyte to adipocyte: differentiation-directed signals of 
insulin from the cell surface to the nucleus. Crit Rev Clin Lab Sci Vol.36, No.1, pp. 1-
34, ISSN 1040-8363 
Sterodimas, A., de Faria, J., Nicaretta, B., and Pitanguy, I. (2010). Tissue engineering with 
adipose-derived stem cells (ADSCs): current and future applications. J Plast 
Reconstr Aesthet Surg Vol.63, No.11, pp. 1886-92, ISSN 1878-0539  
Stillaert, F. B., Di Bartolo, C., Hunt, J. A., Rhodes, N. P., Tognana, E., Monstrey, S., and 
Blondeel, P. N. (2008). Human clinical experience with adipose precursor cells 
seeded on hyaluronic acid-based spongy scaffolds. Biomaterials Vol.29, No.29, pp. 
3953-9, ISSN 0142-9612  
Tchkonia, T., Giorgadze, N., Pirtskhalava, T., Tchoukalova, Y., Karagiannides, I., Forse, R. 
A., DePonte, M., Stevenson, M., Guo, W., Han, J., Waloga, G., Lash, T. L., Jensen, M. 
D., and Kirkland, J. L. (2002). Fat depot origin affects adipogenesis in primary 
cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol 
Vol.282, No.5, pp. R1286-96, ISSN 0363-6119  
www.intechopen.com
  
Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 
 
194 
Toyoda, M., Matsubara, Y., Lin, K., Sugimachi, K., and Furue, M. (2009). Characterization 
and comparison of adipose tissue-derived cells from human subcutaneous and 
omental adipose tissues. Cell Biochem Funct Vol.27, No.7, pp. 440-7, ISSN 1099-0844  
von Heimburg, D., Zachariah, S., Heschel, I., Kuhling, H., Schoof, H., Hafemann, B., and 
Pallua, N. (2001). Human preadipocytes seeded on freeze-dried collagen scaffolds 
investigated in vitro and in vivo. Biomaterials Vol.22, No.5, pp. 429-38, ISSN 0142-9612  
von Heimburg, D., Zachariah, S., Low, A., and Pallua, N. (2001). Influence of different 
biodegradable carriers on the in vivo behavior of human adipose precursor cells. 
Plast Reconstr Surg Vol.108, No.2, pp. 411-20; discussion 421-2, ISSN 0032-1052  
Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., 
Turner, D., Rupp, R., Hollenberg, S., and et al. (1991). The myoD gene family: nodal 
point during specification of the muscle cell lineage. Science Vol.251, No.4995, pp. 
761-6, ISSN 0036-8075 
Wickham, M. Q., Erickson, G. R., Gimble, J. M., Vail, T. P., and Guilak, F. (2003). Multipotent 
stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat 
Res, No.412, pp. 196-212, ISSN 0009-921X  
Yoshimura, K., Sato, K., Aoi, N., Kurita, M., Hirohi, T., and Harii, K. (2008). Cell-assisted 
lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived 
stem/stromal cells. Aesthetic Plast Surg Vol.32, No.1, pp. 48-55; discussion 56-7, 
ISSN 0364-216X  
Yuan, Q., Zeng, X., Chen, L., Peng, E., and Ye, Z. (2010). [Comparison of myogenic differentiation 
ability of adipose-derived stem cells from different sites in rabbit]. Zhongguo Xiu 
Fu Chong Jian Wai Ke Za Zhi Vol.24, No.10, pp. 1228-32, ISSN 1002-1892  
Zhang, J., Shehabeldin, A., da Cruz, L. A., Butler, J., Somani, A. K., McGavin, M., 
Kozieradzki, I., dos Santos, A. O., Nagy, A., Grinstein, S., Penninger, J. M., and 
Siminovitch, K. A. (1999). Antigen receptor-induced activation and cytoskeletal 
rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient 
lymphocytes. J Exp Med Vol.190, No.9, pp. 1329-42, ISSN 0022-1007  
Zhang, Y. S., Gao, J. H., Lu, F., Zhu, M., and Liao, Y. J. (2007). [Cellular compatibility of type 
collagen I scaffold and human adipose-derived stem cells]. Nan Fang Yi Ke Da Xue 
Xue Bao Vol.27, No.2, pp. 223-5, ISSN 1673-4254  
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., 
Fraser, J. K., Benhaim, P., and Hedrick, M. H. (2002). Human adipose tissue is a source 
of multipotent stem cells. Mol Biol Cell Vol.13, No.12, pp. 4279-95, ISSN 1059-1524  
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., 
and Hedrick, M. H. (2001). Multilineage cells from human adipose tissue: implications 
for cell-based therapies. Tissue Eng Vol.7, No.2, pp. 211-28, ISSN 1076-3279 
www.intechopen.com
Regenerative Medicine and Tissue Engineering - Cells and
Biomaterials
Edited by Prof. Daniel Eberli
ISBN 978-953-307-663-8
Hard cover, 588 pages
Publisher InTech
Published online 29, August, 2011
Published in print edition August, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Tissue Engineering may offer new treatment alternatives for organ replacement or repair deteriorated organs.
Among the clinical applications of Tissue Engineering are the production of artificial skin for burn patients,
tissue engineered trachea, cartilage for knee-replacement procedures, urinary bladder replacement, urethra
substitutes and cellular therapies for the treatment of urinary incontinence. The Tissue Engineering approach
has major advantages over traditional organ transplantation and circumvents the problem of organ shortage.
Tissues reconstructed from readily available biopsy material induce only minimal or no immunogenicity when
reimplanted in the patient. This book is aimed at anyone interested in the application of Tissue Engineering in
different organ systems. It offers insights into a wide variety of strategies applying the principles of Tissue
Engineering to tissue and organ regeneration.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Mathias Tremp, Souzan Salemi, Rita Gobet, Tullio Sulser and Daniel Eberli (2011). Adipose-Derived Stem
Cells (ASCs) for Tissue Engineering, Regenerative Medicine and Tissue Engineering - Cells and Biomaterials,
Prof. Daniel Eberli (Ed.), ISBN: 978-953-307-663-8, InTech, Available from:
http://www.intechopen.com/books/regenerative-medicine-and-tissue-engineering-cells-and-
biomaterials/adipose-derived-stem-cells-ascs-for-tissue-engineering
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
